Advertisement

Hematologic Disorders: Hemochromatosis, Hemoglobinopathies, and Rh Incompatibility

  • Daniel B. Bellissimo
Chapter
  • 1.7k Downloads

Abstract

Hereditary hemochromatosis (HHC) is an autosomal recessive disorder of iron metabolism resulting from excess iron storage in the liver, skin, pancreas, heart, joints, testes, and pituitary gland. If left untreated, life-threatening complications such as cirrhosis, diabetes, liver cancer, and cardiomyopathy may result. Iron overload and the resulting clinical complications can be avoided by early diagnosis and periodic phlebotomy to reduce the body’s iron stores.

Keywords

Hereditary Hemochromatosis Locus Control Region H63D Mutation Polymerase Chain Reaction Restriction Fragment Length Polymorphism Maternal Cell Contamination 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399–408.PubMedCrossRefGoogle Scholar
  2. 2.
    Hanson EH, Imperatore G, Burke W. HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology. Am J Epidemiol. 2001;154:193–206.PubMedCrossRefGoogle Scholar
  3. 3.
    Lyon E, Frank EL. Hereditary hemochromatosis since discovery of the HFE gene. Clin Chem. 2001;47:1147–1156.PubMedGoogle Scholar
  4. 4.
    Imperatore G, Pinsky LE, Motulsky A, Reyes M, Bradley LA, Burke W. Hereditary hemochromatosis: perspectives of public health, medical genetics, and primary care. Genet Med. 2003;5:1–8.PubMedGoogle Scholar
  5. 5.
    Camaschella C, Roetto A, Cali A, et al. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet. 2000;25:14–15.PubMedCrossRefGoogle Scholar
  6. 6.
    Njajou OT, Vaessen N, Joosse M, et al. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet. 2001;28:213–214.PubMedCrossRefGoogle Scholar
  7. 7.
    Burke W, Imperatore G, McDonnell SM, Baron RC, Khoury MJ. Contribution of different HFE genotypes to iron overload disease: a pooled analysis. Genet Med. 2000;2:271–277.PubMedCrossRefGoogle Scholar
  8. 8.
    Somerville MJ, Sprysak KA, Hicks M, Elyas BG, Vicen-Wyhony L. An HFE intronic variant promotes misdiagnosis of hereditary hemochromatosis. Am J Hum Genet. 1999;65:924–926.PubMedCrossRefGoogle Scholar
  9. 9.
    Beutler E, Gelbart T. A common intron 3 mutation (IVS3-48c→g) leads to misdiagnosis of the c.845G→A (C282Y) HFE gene mutation. Blood Cells Mol Dis. 2000;26:229–233.PubMedCrossRefGoogle Scholar
  10. 10.
    Pointon JJ, Merryweather-Clarke AT, Carella M, Robson KJ. Detection of C282Y and H63D in the HFE gene. Genet Test. 2000;4:115–120.PubMedCrossRefGoogle Scholar
  11. 11.
    Weatherall DJ, Clegg JB, Higgs DR, Wood WG. The hemoglobinopathies. In: Scriver CR, Beaudet AL, Sly W, Valle D, eds.The Metabolic and Molecular Basis of Inherited Disease. 8th ed. New York: McGraw-Hill; 2001:4571–4636.Google Scholar
  12. 12.
    Gay JC, Phillips JA III, Kazazian HH. Hematoglobinopathies and thalassemias. In: Rimoin DL, Connor JM, Pyeritz RE, eds. Emery and Rimoin’s Principles and Practices of Medical Genetics. New York: Churchill Livingstone; 1997:1599–1626.Google Scholar
  13. 13.
    Cao A, Galanello R. Beta-thalassemia. GeneReviews [database online]. Seattle, WA: University of Washington. Updated March 18, 2003.Google Scholar
  14. 14.
    Hatcher SL, Trang QT, Robb KM, Teplitz RL, Carlson JR. Prenatal diagnosis by enzymatic amplification and restriction endonuclease digestion for detection of haemoglobins A, S and C. Mol Cell Probes. 1992;6:343–348.PubMedCrossRefGoogle Scholar
  15. 15.
    Hermann MG. Genotyping β-globin mutations (HbS, HbC, HbE) by multiplexing probe color and melting temperature. In: Meuer S, Wittwer CT, Nakagawara K, eds. Rapid Cycle Real-Time PCR: Methods and Applications. Heidelberg: Springer-Verlag; 2001:119–125.Google Scholar
  16. 16.
    Kattamis AC, Camaschella C, Sivera P, Surrey S, Fortina P. Human alpha-thalassemia syndromes: detection of molecular defects. Am J Hematol. 1996;53:81–91.PubMedCrossRefGoogle Scholar
  17. 17.
    Tan AS, Quah TC, Low PS, Chong SS. A rapid and reliable 7-deletion multiplex polymerase chain reaction assay for alpha-thalassemia. Blood. 2001;98:250–251.PubMedCrossRefGoogle Scholar
  18. 18.
    Tuzmen S, Schechter AN. Genetic diseases of hemoglobin: diagnostic methods for elucidating beta-thalassemia mutations. Blood Rev. 2001;15:19–29.PubMedCrossRefGoogle Scholar
  19. 19.
    Moreno I, Bolufer P, Perez ML, Barragan E, Sanz MA. Rapid detection of the major Mediterranean beta-thalassaemia mutations by real-time polymerase chain reaction using fluorophorelabelled hybridization probes. Br J Haematol. 2002;119:554–557.PubMedCrossRefGoogle Scholar
  20. 20.
    Avent ND, Reid ME. The Rh blood group system: a review. Blood. 2000;95:375–387.PubMedGoogle Scholar
  21. 21.
    Bowman JM. Immune hemolytic disease. In: Nathan DG, Oski FA, eds. Hematology of Infancy and Childhood. Philadelphia: W. b. Saunders; 1998:53–78.Google Scholar
  22. 22.
    van der Schoot CE, Tax GH, Rijnders RJ, de Haas M, Christiaens GC. Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed. Transfus Med Rev. 2003;17:31–44.PubMedCrossRefGoogle Scholar
  23. 23.
    Singleton BK, Green CA, Avent ND, et al. The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in Africans with the Rh D-negative blood group phenotype. Blood. 2000;95:12–18.PubMedGoogle Scholar
  24. 24.
    Wagner FF, Flegel WA. RHD gene deletion occurred in the Rhesus box. Blood. 2000;95:3662–3668.PubMedGoogle Scholar
  25. 25.
    Wagner FF, Frohmajer A, Flegel WA. RHD positive haplotypes in D negative Europeans. BMC Genet. 2001;2:10.PubMedCrossRefGoogle Scholar
  26. 26.
    Finning KM, Martin PG, Soothill PW, Avent ND. Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion. 2002;42:1079–1085.PubMedCrossRefGoogle Scholar
  27. 27.
    Stamatoyannopoulos G, Nienhuis AW. Hemoglobin switching. In: Stamatoyannopoulos G, Nienhuis AW, Majerus PW, Varmus H, eds. The Molecular Basis of Blood Diseases. Philadelphia: W. b. Saunders; 1994:107–155.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Daniel B. Bellissimo
    • 1
  1. 1.Molecular Diagnostics LaboratoryBlood Center of Southeastern WisconsinMilwaukeeUSA

Personalised recommendations